Expertise in
4
conditions

Rainer Hambrecht

Bremen, HB, DE 
Expertise in
4
conditions
Bremen, HB, DE 
OverviewLocationsClinical Research

Overview

Rainer Hambrecht practices in Bremen, Germany. Mr. Hambrecht is highly rated in 4 conditions, according to our data. His top areas of expertise are Heart Attack, Cardiogenic Shock, Heart Failure, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bremen, HB, Germany
Other Locations
Germany
Leipzig, SN, Germany
Frankfurt Am Main, HE 60590, Germany
Ludwigshafen Am Rhein, RP, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG
A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG
Enrollment Status: Terminated
Publish Date: August 02, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

100 Total Publications

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
Journal: The New England journal of medicine
Published: August 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hambrecht's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile